SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000014272-18-000020
Filing Date
2018-01-03
Accepted
2018-01-03 18:33:49
Documents
1
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_151502241512490.html 4  
1 FORM 4 wf-form4_151502241512490.xml 4 4230
  Complete submission text file 0000014272-18-000020.txt   5688
Mailing Address 345 PARK AVE NEW YORK NY 10154
Business Address 345 PARK AVE NEW YORK NY 10154 2125464000
BRISTOL MYERS SQUIBB CO (Issuer) CIK: 0000014272 (see all company filings)

IRS No.: 220790350 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O VERTEX PHARMACEUTICALS INCORPORATED 130 WAVERLY ST., ATTN: GENERAL COUNSEL CAMBRIDGE MA 02139
Business Address
Emmens Matthew (Reporting) CIK: 0001298332 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-01136 | Film No.: 18507512